{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:50:01Z","timestamp":1791053401282,"version":"4.1.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Activated protein C (PC) is an anticoagulant involved in the interactions between the coagulation and immune systems. Activated PC has broad anti-inflammatory effects that are mediated through its ability to modulate leukocyte function and confer vascular barrier protection. We investigated the influence of activated PC on the pathogenesis of experimental autoimmune encephalomyelitis (EAE), the animal model for multiple sclerosis. We modulated activated PC levels in the circulation during EAE induction through systemic administration of a mAb against PC\/activated PC (anti-PC). We initially hypothesized that inhibition of activated PC may result in a heightened inflammatory environment, leading to increased EAE pathogenesis. Contrary to this hypothesis, mice treated with anti-PC Ab (anti-PC mice) exhibited attenuated EAE. Interestingly, despite reduced disease severity and minimal pathogenic conditions in the CNS, anti-PC mice exhibited considerable leukocyte infiltration in the brain, comparable to control mice with severe EAE. Furthermore, CD4+ T cells were diminished in the periphery of anti-PC mice, whereas various CD11b+ populations were increased, notably the myeloid-derived suppressor cells (MDSCs), a CD11b+ subset characterized as potent T cell suppressors. MDSCs from anti-PC mice exhibited increased expression of T cell suppressive factors and effectively inhibited T cell proliferation. Overall, our findings show that activated PC inhibition affected EAE pathogenesis at multiple fronts, specifically increasing vascular barrier permeability, as evidenced by considerable leukocyte infiltration in the brain. Additionally, inhibition of activated PC modulated the functional responses of CD11b+ cells, leading to the expansion and increased activation of MDSCs, which are suppressive to the CD4+ T cells required for EAE progression, thereby resulting in attenuated EAE.<\/jats:p>","DOI":"10.4049\/jimmunol.1202556","type":"journal-article","created":{"date-parts":[[2013,8,31]],"date-time":"2013-08-31T04:32:38Z","timestamp":1377923558000},"page":"3764-3777","source":"Crossref","is-referenced-by-count":32,"title":["Inhibition of Endogenous Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis by Inducing Myeloid-Derived Suppressor Cells"],"prefix":"10.1093","volume":"191","author":[{"given":"Leah M","family":"Alabanza","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University , Ithaca, NY 14853"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi L","family":"Esmon","sequence":"additional","affiliation":[{"name":"Coagulation Biology Laboratory, Oklahoma Medical Research Foundation , Oklahoma City, OK 73104"},{"name":"Department of Pathology, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles T","family":"Esmon","sequence":"additional","affiliation":[{"name":"Coagulation Biology Laboratory, Oklahoma Medical Research Foundation , Oklahoma City, OK 73104"},{"name":"Department of Pathology, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104"},{"name":"Howard Hughes Medical Institute , Oklahoma City, OK 73104"},{"name":"Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret S","family":"Bynoe","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University , Ithaca, NY 14853"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,1]]},"reference":[{"key":"2025032405412446000_r1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00281-011-0284-6","article-title":"Protein C anticoagulant system\u2014anti-inflammatory effects","volume":"34","author":"Esmon","year":"2012","journal-title":"Semin. Immunopathol."},{"issue":"2","key":"2025032405412446000_r2","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/CCM.0b013e3181c9cbb5","article-title":"Regulation of inflammation by the protein C system","volume":"38","author":"Weiler","year":"2010","journal-title":"Crit. Care Med."},{"key":"2025032405412446000_r3","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","article-title":"The cytoprotective protein C pathway","volume":"109","author":"Mosnier","year":"2007","journal-title":"Blood"},{"key":"2025032405412446000_r4","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/01.ATV.0000134298.25489.92","article-title":"Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation","volume":"24","author":"Van de Wouwer","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025032405412446000_r5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.mvr.2012.03.003","article-title":"Activated protein C improves pial microcirculation in experimental endotoxemia in rats","volume":"83","author":"Zhou","year":"2012","journal-title":"Microvas. Res."},{"key":"2025032405412446000_r6","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1182\/blood-2004-10-3985","article-title":"Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation","volume":"105","author":"Feistritzer","year":"2005","journal-title":"Blood"},{"key":"2025032405412446000_r7","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2009-04-217679","article-title":"Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement","volume":"114","author":"Van Sluis","year":"2009","journal-title":"Blood"},{"key":"2025032405412446000_r8","doi-asserted-by":"crossref","first-page":"e15352","DOI":"10.1371\/journal.pone.0015352","article-title":"Transcriptome analysis revealed unique genes as targets for the anti-inflammatory action of activated protein C in human macrophages","volume":"5","author":"Pereira","year":"2010","journal-title":"PLoS ONE"},{"key":"2025032405412446000_r9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/ATVBAHA.107.157438","article-title":"Wnt5A\/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10","volume":"28","author":"Pereira","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025032405412446000_r10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2141.2000.02128.x","article-title":"Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line","volume":"110","author":"White","year":"2000","journal-title":"Br. J. Haematol."},{"key":"2025032405412446000_r11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0037-1613197","article-title":"Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes","volume":"88","author":"Yuksel","year":"2002","journal-title":"Thromb. Haemost."},{"key":"2025032405412446000_r12","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1074\/jbc.C100017200","article-title":"Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis","volume":"276","author":"Joyce","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2025032405412446000_r13","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4049\/jimmunol.177.4.2115","article-title":"Modulation of monocyte function by activated protein C, a natural anticoagulant","volume":"177","author":"Stephenson","year":"2006","journal-title":"J. Immunol."},{"key":"2025032405412446000_r14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0014-5793(00)01740-3","article-title":"Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner","volume":"477","author":"Shua","year":"2000","journal-title":"FEBS Lett."},{"key":"2025032405412446000_r15","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1172\/JCI40380","article-title":"The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b","volume":"120","author":"Cao","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2025032405412446000_r16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"2025032405412446000_r17","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"2025032405412446000_r18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1473-3099(12)70175-5","article-title":"The rise and fall of drotrecogin alfa (activated)","volume":"12","author":"Vincent","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"2025032405412446000_r19","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/01.CIR.103.13.1799","article-title":"Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke","volume":"103","author":"Shibata","year":"2001","journal-title":"Circulation"},{"key":"2025032405412446000_r20","first-page":"3437","article-title":"Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells","volume":"119","author":"Zhong","year":"2009","journal-title":"J. Clin. Invest."},{"key":"2025032405412446000_r21","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1172\/JCI31027","article-title":"Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease","volume":"117","author":"Scaldaferri","year":"2007","journal-title":"J. Clin. Invest."},{"key":"2025032405412446000_r22","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1164\/ajrccm.163.7.9911068","article-title":"Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse","volume":"163","author":"Yasui","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2025032405412446000_r23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ni1507","article-title":"Multiple sclerosis: a complicated picture of autoimmunity","volume":"8","author":"McFarland","year":"2007","journal-title":"Nat. Immunol."},{"key":"2025032405412446000_r24","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"2025032405412446000_r25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.aanat.2010.06.006","article-title":"Emerging concepts in autoimmune encephalomyelitis beyond the CD4\/T(H)1 paradigm","volume":"192","author":"Batoulis","year":"2010","journal-title":"Ann. Anat."},{"key":"2025032405412446000_r26","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nature06559","article-title":"Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets","volume":"451","author":"Han","year":"2008","journal-title":"Nature"},{"key":"2025032405412446000_r27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-5728(93)90024-S","article-title":"Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease","volume":"47","author":"Koh","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"2025032405412446000_r28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-510X(01)00468-3","article-title":"Plasma thrombin-antithrombin III complex is associated with the severity of experimental autoimmune encephalomyelitis","volume":"185","author":"Inaba","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"2025032405412446000_r29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","article-title":"Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function","volume":"32","author":"Condamine","year":"2011","journal-title":"Trends Immunol."},{"key":"2025032405412446000_r30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1538-7836.2009.03333.x","article-title":"Endogenous activated protein C signaling is critical to protection of mice from lipopolysaccaride-induced septic shock","volume":"7","author":"Xu","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"2025032405412446000_r31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0022-1759(94)90027-2","article-title":"Determination of arginase activity in macrophages: a micromethod","volume":"174","author":"Corraliza","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"2025032405412446000_r32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.1992.tb39753.x","article-title":"Neutrophils, nitrogen oxides, and inflammatory bowel disease","volume":"664","author":"Grisham","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025032405412446000_r33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jmri.10136","article-title":"Imaging inflammation: direct visualization of perivascular cuffing in EAE by magnetic resonance microscopy","volume":"16","author":"Gareau","year":"2002","journal-title":"J. Magn. Reson. Imaging"},{"key":"2025032405412446000_r34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"2025032405412446000_r35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cne.21307","article-title":"Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis","volume":"502","author":"Brown","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"2025032405412446000_r36","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.4049\/jimmunol.1200545","article-title":"A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis","volume":"188","author":"Mills","year":"2012","journal-title":"J. Immunol."},{"key":"2025032405412446000_r37","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.176.6.3293","article-title":"Mechanisms of immunopathology in murine models of central nervous system demyelinating disease","volume":"176","author":"Ercolini","year":"2006","journal-title":"J. Immunol."},{"key":"2025032405412446000_r38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/CJI.0b013e318242169f","article-title":"Myeloid-derived suppressor cells in cancer patients: a clinical perspective","volume":"35","author":"Montero","year":"2012","journal-title":"J. Immunother."},{"key":"2025032405412446000_r39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"2025032405412446000_r40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.intimp.2011.01.026","article-title":"MDSC in autoimmunity","volume":"11","author":"Cripps","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"2025032405412446000_r41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellimm.2005.01.004","article-title":"L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes","volume":"232","author":"Zea","year":"2004","journal-title":"Cell. Immunol."},{"key":"2025032405412446000_r42","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/ATVBAHA.107.153734","article-title":"Activated protein C decreases tumor necrosis factor related apoptosis-inducing ligand by an EPCR-independent mechanism involving Egr-1\/Erk-1\/2 activation","volume":"27","author":"O\u2019Brien","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025032405412446000_r43","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.181.3.2165","article-title":"Activated protein C up-regulates IL-10 and inhibits tissue factor in blood monocytes","volume":"181","author":"Toltl","year":"2008","journal-title":"J. Immunol."},{"key":"2025032405412446000_r44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.coi.2010.12.006","article-title":"Transcription factors in myeloid-derived suppressor cell recruitment and function","volume":"23","author":"Sonda","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"2025032405412446000_r45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1073\/pnas.0807594106","article-title":"Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells","volume":"106","author":"Yang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032405412446000_r46","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.4049\/jimmunol.179.8.5228","article-title":"CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis","volume":"179","author":"Zhu","year":"2007","journal-title":"J. Immunol."},{"key":"2025032405412446000_r47","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1750-3639.2011.00495.x","article-title":"Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis","volume":"21","author":"Molin\u00e9-Vel\u00e1zquez","year":"2011","journal-title":"Brain Pathol."},{"key":"2025032405412446000_r48","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"key":"2025032405412446000_r49","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4049\/jimmunol.171.3.1232","article-title":"L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes","volume":"171","author":"Rodriguez","year":"2003","journal-title":"J. Immunol."},{"key":"2025032405412446000_r50","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.4049\/jimmunol.160.12.5729","article-title":"Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3\/STAT5 signaling pathway","volume":"160","author":"Bingisser","year":"1998","journal-title":"J. Immunol."},{"key":"2025032405412446000_r51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"2025032405412446000_r52","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res."},{"key":"2025032405412446000_r53","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-07-6621","article-title":"Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells","volume":"68","author":"Serafini","year":"2008","journal-title":"Cancer Res."},{"key":"2025032405412446000_r54","first-page":"457","article-title":"Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells","volume":"120","author":"Chalmin","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2025032405412446000_r55","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.ajpath.2011.06.028","article-title":"Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis","volume":"179","author":"Wu","year":"2011","journal-title":"Am. J. Pathol."},{"key":"2025032405412446000_r56","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/jir.2011.0072","article-title":"The immune pathogenesis of experimental autoimmune encephalomyelitis: lessons learned for multiple sclerosis?","volume":"31","author":"Kuerten","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"2025032405412446000_r57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neulet.2011.03.021","article-title":"Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and score-dependent","volume":"494","author":"Recks","year":"2011","journal-title":"Neurosci. Lett."},{"key":"2025032405412446000_r58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI12440","article-title":"Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels","volume":"108","author":"Vajkoczy","year":"2001","journal-title":"J. Clin. Invest."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/191\/7\/3764\/62510402\/1202556.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/191\/7\/3764\/62510402\/1202556.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T05:43:13Z","timestamp":1742881393000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/191\/7\/3764\/7989681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1202556","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,10]]},"published":{"date-parts":[[2013,10,1]]}}}